Protection
NDC 52124-0114
Product Information
Protection is a OTC MONOGRAPH FINAL-approved product labeled by Genuine First Aid Llc. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a orange product. This product entry covers the primary NDC 52124-0114 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
ASPIRIN
Code Structure Chart
Product Details
What is NDC 52124-0114?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- ISOPROPYL ALCOHOL (UNII: ND2M416302)
- ISOPROPYL ALCOHOL (UNII: ND2M416302) (Active Moiety)
- BENZOCAINE (UNII: U3RSY48JW5)
- BENZOCAINE (UNII: U3RSY48JW5) (Active Moiety)
- ALCOHOL (UNII: 3K9958V90M)
- ALCOHOL (UNII: 3K9958V90M) (Active Moiety)
- ASPIRIN (UNII: R16CO5Y76E)
- ASPIRIN (UNII: R16CO5Y76E) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- WATER (UNII: 059QF0KO0R)
- FD&C YELLOW NO. 6 (UNII: H77VEI93A8)
- SACCHARIN (UNII: FST467XS7D)
- SODIUM CATION (UNII: LYR4M0NH37)
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- STARCH, CORN (UNII: O8232NY3SJ)
- STEARIC ACID (UNII: 4ELV7Z65AP)
- SUCROSE (UNII: C151H8M554)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1046313 - benzocaine 6 % / ethanol 60 % Medicated Pad
- RxCUI: 1046313 - benzocaine 60 MG/ML / ethanol 0.6 ML/ML Medicated Pad
- RxCUI: 1046313 - benzocaine 6 % / ethanol 60 % Topical Swab
- RxCUI: 318272 - aspirin 81 MG Chewable Tablet
- RxCUI: 318272 - ASA 81 MG Chewable Tablet
* Please review the full disclaimer at the bottom of this page.